Please assess the completion status of the following clinical trial:

Trial Title: Peritoneal Nebulization of Ropivacaine for Pain Control After Laparoscopic Colectomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Females and Males 18-80 years old~* ASA Score I (American Society of Anesthesiologists classification : a normal healthy patient.~* ASA Score II (American Society of Anesthesiologists classification): A patient with mild systemic disease~* ASA Score III (American Society of Anesthesiologists classification): A patient with severe systemic disease~* Patients scheduled for oncological laparoscopic colectomy~* Patients who do not use opioids analgesic drugs before surgery~* Patients without cognitive impairment or mental retardation~Exclusion Criteria:~* Females and Males under 18 or over 80~* ASA Score IV (American Society of Anesthesiologists classification): A patient with severe systemic disease that is a constant threat to life~* ASA Score V (American Society of Anesthesiologists classification): A moribund patient who is not expected to survive without the operation~* Emergency/urgency surgery~* Postoperative admission in an intensive care unit with sedation or ventilatory assistance~* Cognitive impairment or mental retardation~* Use of opiods before surgery~* Progressive degenerative diseases of the CNS~* Convulsions or chronic therapy with antiepileptic drugs~* Severe hepatic or renal impairment~* Allergy to one of the specific drugs under study~* Acute infection or inflammatory chronic disease~* Alcohol or drug addiction~* Any kind of communication problem~* Neurologic or psychiatric disease

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Ropivacaine 150 mg (Type: EXPERIMENTAL): Nebulization of Ropivacaine 150 mg in the peritoneal cavity with the Aeroneb Pro system
- Saline 15 ml (Type: PLACEBO_COMPARATOR): Nebulization of Saline 15 ml in the peritoneal cavity with the Aeroneb Pro system

Based on this trial design, predict the completion outcome and termination type (if applicable).